VIDIS is an international diabetes group of scientists and clinicians studying the relationships between viral infection and the development of type 1 (insulin dependent) diabetes.
Growing evidence suggests that infection with a member of a very common family of viruses, known as enteroviruses, may be responsible for triggering the events that lead to the onset of type 1 diabetes in a large proportion of patients. The Virus in Diabetes International Study Group (VIDIS) is examining this link and studying the possibility that development of a vaccine could, in the future, protect those individuals who are at genetic risk of developing type 1 diabetes.
The VIDIS Group aims to foster collaboration between researchers in their common goal to prevent type 1 diabetes.
“If a virus is involved then vaccination as a preventative measure is a realistic possibility” (Professor Keith Taylor)
Keith Taylor established VIDIS in 2007
The VIDIS Group
Keith Taylor, spent his career trying to convince people of the link between viruses and type 1 diabetes (he was diagnosed with diabetes himself as a student). As early as 1970 he began to question the seasonal nature of the presentation of type 1 diabetes and an association with antibodies to Coxsackie B4 viruses. Forty years later these theories were being proven when viral particles could be detected in the pancreatic islets of newly-diagnosed patients. Keith co-edited a book on the role virus played in type 1 diabetes which was published in 2012 (Diabetes and Viruses, New York, London, Springer) and established an international group, Viruses in Diabetes International Study Group (VIDIS). His final paper appeared posthumously (‘Virus antibody survey in different European populations indicates risk association between coxsackie virus B1 and type 1 diabetes.’ Diabetes. 2014 Feb;63:655-62).